ACE inhibitors and ARBs may reduce the risk of thrombotic complications in hypertension by modulating the renin-angiotensin and kallikrein-kinin systems.
No takes yet. Share an insight, caveat, or question.
May inform ACEI/ARB choice in high-thrombosis-risk hypertension; hypothesis-generating and requires prospective validation before practice change.
Dielis et al. (2005) studied this question.